Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8769 - 8776 of 11370 results
ML Strategies: Health Care Update & Telehealth Policy Alert
June 3, 2015| Blog| Viewpoint
Home Depot Moves to Dismiss Consumer Data Breach Claims for Lack of Standing
June 3, 2015| Blog| Viewpoint
The Supreme Court Takes the BIA to Task
June 2, 2015| Blog| Viewpoint
Harm to Potential Competition Triggers FTC Merger Challenge
June 2, 2015| Alert| Viewpoint
Health Care Update & Telehealth Policy Alert
June 2, 2015| Alert| Viewpoint
FY2016 Massachusetts Budget Update: The Senate Budget
June 2, 2015| Alert| Viewpoint
CleanEdge U.S. Clean Tech Index – Which Cities and States Are Clean Energy Leaders
June 2, 2015| Blog| Viewpoint
Big Win for Anti-GMO Groups as Federal Judge Upholds Jackson County GMO Ban
June 2, 2015| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that Member and Chair of the firm’s Intellectual Property Division Michael Renaud and Members Matthew Galica, Frank Gerratana, Marguerite McConihe, Michael Newman, Adam Rizk, and James Wodarski have been named to the 2024 IAM Strategy 300: The World’s Leading IP Strategists list.
Medicare Drug Price Cuts Add Fuel to Legal Fight Over Program
August 16, 2024
Member Rachel Alexander was quoted in a recent Bloomberg Law article about Medicare drug price cuts and what they might mean for ongoing litigation. Rachel addresses the potential implications of the US government’s release Thursday of the first ten drug prices that were negotiated for Medicare.
Seven Mintz attorneys were recognized in Benchmark Litigation’s 2024 “40 & Under List” which spotlights the “top emerging talent in litigation” who are 40 years old and under. The annual “40 & Under List” is compiled through peer and client review, as well as consideration of individual cases.